Biohaven BHVN Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number at other companies

General DynamicsGD

9M-10.9%

The Travelers CompaniesTRV

6.2M-11.6%

Phillips 66PSX

2.8M-29.3%

WaFd, Inc.WAFD

827.8K-1.8%

Arthur J. GallagherAJG

7.6M—

WSFS FinancialWSFS

0-100%

Other financials

Income statement

See full

Operating income-$130.4M+41.1%

Net income-$130.5M+41.1%

EPS (diluted)-$0.88+59.4%

Balance sheet

See full

Cash & equivalents$277.1M+170%

Total debt$286.2M+706%

Total equity$129.5M-50.1%

Total assets$466.4M+1.6%

Cash flow

See full

Operating cash flow-$149.9M+9.2%

CapEx--100%

Free cash flow-$149.9M+9.5%

Valuation

See full

Market cap$2.25B-48.1%

Enterprise value$2.26B-46.3%

Returns & leverage

See full

Return on equity-333%+17.9pp

Debt / equity2.2×+2.1×

Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biohaven's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number?: Biohaven (BHVN) reported share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number of $20.31M in Q1 2026.
How has Biohaven's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number changed year-over-year?: Biohaven's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number increased by 31.6% year-over-year, from $15.43M to $20.31M.